4//SEC Filing
Pauls Dietrich John 4
Accession 0001235802-19-000064
CIK 0001401040other
Filed
Jun 25, 8:00 PM ET
Accepted
Jun 26, 4:42 PM ET
Size
6.2 KB
Accession
0001235802-19-000064
Insider Transaction Report
Form 4
Pauls Dietrich John
DirectorPresident & CEO
Transactions
- Award
Stock Option (right to buy)
2019-06-24+264,000→ 264,000 totalExercise: $4.60Exp: 2029-06-23→ Common Shares (264,000 underlying)
Holdings
- 29,804
Voting Common Shares, no par value per share
Footnotes (2)
- [F1]Includes 1,749 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan.
- [F2]Vests in eight equal quarterly installments over two years.
Documents
Issuer
DiaMedica Therapeutics Inc.
CIK 0001401040
Entity typeother
Related Parties
1- filerCIK 0001760123
Filing Metadata
- Form type
- 4
- Filed
- Jun 25, 8:00 PM ET
- Accepted
- Jun 26, 4:42 PM ET
- Size
- 6.2 KB